Table 2.
Preoperative patient baseline characteristics.
| Isolated CABG | Valvular surgery | Aortic surgery | |
|---|---|---|---|
| Number of patients | 4 | 17 | 5 |
| Age (yr) | 50 ± 16 (34–67) | 54 ± 12 (41–72) | 67 ± 11 (55–81) |
| Female sex | 4 (100%) | 15 (88%) | 5 (100%) |
| Body mass index (kg/m2) | 21.42 ± 3.66 | 20.87 ± 2.71 | 18.40 ± 2.02 |
| Body surface area (m2) | 1.49 ± 0.09 | 1.51 ± 0.17 | 1.34 ± 0.09 |
| Brain natriuretic peptide (pg/mL) | 74 ± 95 | 722 ± 2010 | 1667 ± 3540 |
| Diabetes mellitus | 0 | 2 (11.8%) | 3 (60.0%) |
| Hypertension | 2 (50.0%) | 8 (47.1%) | 4 (80.0%) |
| Hyperlipidemia | 3 (75.0%) | 6 (35.3%) | 1 (20.0%) |
| Cerebrovascular accident | 1 (25.0%) | 4 (23.5%) | 2 (40.0%) |
| Estimated glomerular filtration (rate mL/min/1.73 m2) | 72.5 ± 37.0 | 56.5 ± 31.8 | 46.9 ± 26.5 |
| Hemodialysis (Lupus nephritis) | 0 | 3 (17.7%) | 1 (20.0%) |
| Chronic lung disease | 0 | 1 (5.9%) | 0 |
| Malignancy | 1 (25.0%) | 2 (11.8%) | 1 (20.0%) |
| Peripheral vascular disease | 0 | 1 (5.9%) | 0 |
| Previous cardiovascular interventions | 0 | 0 | 0 |
| Coronary artery disease | 4 (100%) | 3 (17.7%) | 2 (40%) |
| Number of diseased vessels 1VD | 0 | 1 | 1 |
| 2VD | 2 | 1 | 0 |
| 3VD | 2 | 1 | 1 |
| Previously PCI | 0 | 1 (5.9%) | 0 |
| Previous cardiac surgery | 1 (25.0%) | 0 | 0 |
| Previous pacemaker implantation | 0 | 0 | 0 |
| Previous atrial fibrillation | 0 | 1 (5.9%) | 0 |
| Euro Score II | 2.23 ± 2.80 | 2.64 ± 1.74 | 15.0 ± 19.0 |
1VD = one vessel disease, 2VD = two vessels disease, 3VD = three vessels disease, CABG = coronary artery bypass surgery, EuroSCORE = European system for cardiac operative risk evaluation, PCI = percutaneous coronary intervention.